Cytokeratin positive cells in bone marrow, tumor biologic parameters of the primary tumor and survival in breast cancer patients (2024)

Abstract

9517 Background: The presence of cytokeratin (CK) positive cells in bone marrow of breast cancer patients is correlated with worse clinical outcome. Therefore these cells were suggested to be derived from the primary tumor and are considered to represent an early metastatic tumor cell spread. Presence of these cells may be associated with highly aggressive breast cancer. We analyzed tumorbiologic parameters in the primary cancer, their correlation to the presence of CK positive cells in bone marrow, and survival of breast cancer patients with locally restricted disease.

METHODS: Bone marrow aspirates of 508 patients with operable breast cancer were analyzed for the presence of CK positive cells. Tissue samples of the primary tumor of 134 patients were analyzed for Ki-67, S-phase fraction, Her-2, estrogen, and progesterone receptor expression. Follow-up data were available for up to 11.2 years (median 9.5 years). Tumorbiologic factors were correlated to bone marrow status and disease-free and overall survival of the patients using chi square and log rank test.

RESULTS: 230 out of 508 patients were 'bone marrow positive' (45%). Presence of CK positive cells was negatively correlated to overall and disease-free survival (p< 0.001). Tumorbiologic parameters such as Ki-67, S-phase-fraction, steroid receptor status was also correlated to survival, however, there was no association of tumorbiologic factors and CK positive cells in bone marrow.

CONCLUSIONS: Presence of CK positive cells in bone marrow of breast cancer patients is independent from characteristics of the primary cancer. This supports the hypothesis of tumor cell dormancy characterized by persistence of these cells after adjuvant therapy and late tumor relapse. No significant financial relationships to disclose.

OriginalspracheEnglisch
Seiten (von - bis)9517
FachzeitschriftJournal of Clinical Oncology
Jahrgang22
Ausgabenummer14_suppl
DOIs
PublikationsstatusVeröffentlicht - 15 Juli 2004

ÖFOS 2012

  • 301209 Pharmazie

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  • Cytokeratin positive cells in bone marrow, tumor biologic parameters of the primary tumor and survival in breast cancer patients (1)

Zugriff auf Dokument

Zitationsweisen

  • APA
  • Author
  • BIBTEX
  • Harvard
  • Standard
  • RIS
  • Vancouver

Gebauer, G., Fehm, T., Maul, H., Baier, P., Scharf, A., Sohn, C. (2004). Cytokeratin positive cells in bone marrow, tumor biologic parameters of the primary tumor and survival in breast cancer patients. Journal of Clinical Oncology, 22(14_suppl), 9517. https://doi.org/10.1200/jco.2004.22.90140.9517

Gebauer, G ; Fehm, T ; Maul, H et al. / Cytokeratin positive cells in bone marrow, tumor biologic parameters of the primary tumor and survival in breast cancer patients. in: Journal of Clinical Oncology. 2004 ; Band 22, Nr. 14_suppl. S. 9517.

@article{199b5c776c594d65b72682c4aeb7999a,

title = "Cytokeratin positive cells in bone marrow, tumor biologic parameters of the primary tumor and survival in breast cancer patients",

abstract = "9517 Background: The presence of cytokeratin (CK) positive cells in bone marrow of breast cancer patients is correlated with worse clinical outcome. Therefore these cells were suggested to be derived from the primary tumor and are considered to represent an early metastatic tumor cell spread. Presence of these cells may be associated with highly aggressive breast cancer. We analyzed tumorbiologic parameters in the primary cancer, their correlation to the presence of CK positive cells in bone marrow, and survival of breast cancer patients with locally restricted disease.METHODS: Bone marrow aspirates of 508 patients with operable breast cancer were analyzed for the presence of CK positive cells. Tissue samples of the primary tumor of 134 patients were analyzed for Ki-67, S-phase fraction, Her-2, estrogen, and progesterone receptor expression. Follow-up data were available for up to 11.2 years (median 9.5 years). Tumorbiologic factors were correlated to bone marrow status and disease-free and overall survival of the patients using chi square and log rank test.RESULTS: 230 out of 508 patients were 'bone marrow positive' (45%). Presence of CK positive cells was negatively correlated to overall and disease-free survival (p< 0.001). Tumorbiologic parameters such as Ki-67, S-phase-fraction, steroid receptor status was also correlated to survival, however, there was no association of tumorbiologic factors and CK positive cells in bone marrow.CONCLUSIONS: Presence of CK positive cells in bone marrow of breast cancer patients is independent from characteristics of the primary cancer. This supports the hypothesis of tumor cell dormancy characterized by persistence of these cells after adjuvant therapy and late tumor relapse. No significant financial relationships to disclose.",

author = "G Gebauer and T Fehm and H Maul and P Baier and A Scharf and C Sohn and W Jaeger",

year = "2004",

month = jul,

day = "15",

doi = "10.1200/jco.2004.22.90140.9517",

language = "English",

volume = "22",

pages = "9517",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

number = "14_suppl",

}

Gebauer, G, Fehm, T, Maul, H, Baier, P, Scharf, A, Sohn, C 2004, 'Cytokeratin positive cells in bone marrow, tumor biologic parameters of the primary tumor and survival in breast cancer patients', Journal of Clinical Oncology, Jg. 22, Nr. 14_suppl, S. 9517. https://doi.org/10.1200/jco.2004.22.90140.9517

Cytokeratin positive cells in bone marrow, tumor biologic parameters of the primary tumor and survival in breast cancer patients. / Gebauer, G; Fehm, T; Maul, H et al.

in: Journal of Clinical Oncology, Band 22, Nr. 14_suppl, 15.07.2004, S. 9517.

Veröffentlichungen: Beitrag in FachzeitschriftMeeting Abstract/Conference PaperPeer Reviewed

TY - JOUR

T1 - Cytokeratin positive cells in bone marrow, tumor biologic parameters of the primary tumor and survival in breast cancer patients

AU - Gebauer, G

AU - Fehm, T

AU - Maul, H

AU - Baier, P

AU - Scharf, A

AU - Sohn, C

AU - Jaeger, W

PY - 2004/7/15

Y1 - 2004/7/15

N2 - 9517 Background: The presence of cytokeratin (CK) positive cells in bone marrow of breast cancer patients is correlated with worse clinical outcome. Therefore these cells were suggested to be derived from the primary tumor and are considered to represent an early metastatic tumor cell spread. Presence of these cells may be associated with highly aggressive breast cancer. We analyzed tumorbiologic parameters in the primary cancer, their correlation to the presence of CK positive cells in bone marrow, and survival of breast cancer patients with locally restricted disease.METHODS: Bone marrow aspirates of 508 patients with operable breast cancer were analyzed for the presence of CK positive cells. Tissue samples of the primary tumor of 134 patients were analyzed for Ki-67, S-phase fraction, Her-2, estrogen, and progesterone receptor expression. Follow-up data were available for up to 11.2 years (median 9.5 years). Tumorbiologic factors were correlated to bone marrow status and disease-free and overall survival of the patients using chi square and log rank test.RESULTS: 230 out of 508 patients were 'bone marrow positive' (45%). Presence of CK positive cells was negatively correlated to overall and disease-free survival (p< 0.001). Tumorbiologic parameters such as Ki-67, S-phase-fraction, steroid receptor status was also correlated to survival, however, there was no association of tumorbiologic factors and CK positive cells in bone marrow.CONCLUSIONS: Presence of CK positive cells in bone marrow of breast cancer patients is independent from characteristics of the primary cancer. This supports the hypothesis of tumor cell dormancy characterized by persistence of these cells after adjuvant therapy and late tumor relapse. No significant financial relationships to disclose.

AB - 9517 Background: The presence of cytokeratin (CK) positive cells in bone marrow of breast cancer patients is correlated with worse clinical outcome. Therefore these cells were suggested to be derived from the primary tumor and are considered to represent an early metastatic tumor cell spread. Presence of these cells may be associated with highly aggressive breast cancer. We analyzed tumorbiologic parameters in the primary cancer, their correlation to the presence of CK positive cells in bone marrow, and survival of breast cancer patients with locally restricted disease.METHODS: Bone marrow aspirates of 508 patients with operable breast cancer were analyzed for the presence of CK positive cells. Tissue samples of the primary tumor of 134 patients were analyzed for Ki-67, S-phase fraction, Her-2, estrogen, and progesterone receptor expression. Follow-up data were available for up to 11.2 years (median 9.5 years). Tumorbiologic factors were correlated to bone marrow status and disease-free and overall survival of the patients using chi square and log rank test.RESULTS: 230 out of 508 patients were 'bone marrow positive' (45%). Presence of CK positive cells was negatively correlated to overall and disease-free survival (p< 0.001). Tumorbiologic parameters such as Ki-67, S-phase-fraction, steroid receptor status was also correlated to survival, however, there was no association of tumorbiologic factors and CK positive cells in bone marrow.CONCLUSIONS: Presence of CK positive cells in bone marrow of breast cancer patients is independent from characteristics of the primary cancer. This supports the hypothesis of tumor cell dormancy characterized by persistence of these cells after adjuvant therapy and late tumor relapse. No significant financial relationships to disclose.

U2 - 10.1200/jco.2004.22.90140.9517

DO - 10.1200/jco.2004.22.90140.9517

M3 - Meeting abstract/Conference paper

C2 - 28016777

VL - 22

SP - 9517

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 14_suppl

ER -

Gebauer G, Fehm T, Maul H, Baier P, Scharf A, Sohn C et al. Cytokeratin positive cells in bone marrow, tumor biologic parameters of the primary tumor and survival in breast cancer patients. Journal of Clinical Oncology. 2004 Jul 15;22(14_suppl):9517. doi: 10.1200/jco.2004.22.90140.9517

Cytokeratin positive cells in bone marrow, tumor biologic parameters of the primary tumor and survival in breast cancer patients (2024)

References

Top Articles
Latest Posts
Article information

Author: Gregorio Kreiger

Last Updated:

Views: 5743

Rating: 4.7 / 5 (57 voted)

Reviews: 80% of readers found this page helpful

Author information

Name: Gregorio Kreiger

Birthday: 1994-12-18

Address: 89212 Tracey Ramp, Sunside, MT 08453-0951

Phone: +9014805370218

Job: Customer Designer

Hobby: Mountain biking, Orienteering, Hiking, Sewing, Backpacking, Mushroom hunting, Backpacking

Introduction: My name is Gregorio Kreiger, I am a tender, brainy, enthusiastic, combative, agreeable, gentle, gentle person who loves writing and wants to share my knowledge and understanding with you.